1.Determination of flavonoids in tender stem and leaf of Ampelosis prossedentata by differential spectrophotometry
Jieping QIN ; Shandan LIANG ; Cuiwei HE ;
Chinese Traditional and Herbal Drugs 1994;0(07):-
Object To develop a method for the determination of flavonoids from the tender stem and leaf of Ampelosis grossedentata (Hand. Mazz.) W. T. Wang, and for its quality control. Methods Differential spectrophotometry was used at the wavelength of (318?1) nm, while taking dihydromyricetin as index. Results The regression equation, within the range of the control concentration in 4 576~22 88 ?g/mL, was A=29 56 C+0 005 5, with a good linearity (r=0 999 8) between the absorbance and concentration. The average recovery rate was 100 8% and RSD was 1 9% (n=5). Conclusion The method is simple, reliable and easy to operate and suitable for the quality control of Chinese medicinal materials with a better reproducibility.
2.MRI diagnosis of soft tissue hemangiomas
Qingrong SUN ; Li WEN ; Kaiyun LIANG ; Cuiwei LIAO ;
Journal of Third Military Medical University 2003;0(24):-
Objective To explore the MRI features of soft tissue hemangiomas. Methods The size, margin, morphology and signal pattern of the lesions in MRI findings in 18 patients with soft tissue hemangiomas proved pathologically were retrospectively analyzed. Results Of the 18 cases, there were 8 cases of angiocavernoma (1 0-4 0 cm in size) with clear border, homogeneous high signal in the lesion and low signal ring on the border, 5 cases of intramuscular hemangioma, presented as irregular mass with mixed signals mainly composed of high signal on T2WI, 3 cases of angioma arteriale racemosu with tortuous dilation of blood vessel and amyotrophy as its MRI feature, and 2 cases of venous angioma with thick wall of vein but without supplying arteries. Conclusion Soft tissue hemangioma can usually be diagnosed correctly according to MRI characteristics and clinical data.
3.Study of manifestation of HCC on SPIO-enhanced MRI with pathologic basis in rats
Cuiwei LIAO ; Liguang ZOU ; Jing WEI ; Weijin LIU ; Kaiyun LIANG
Journal of Third Military Medical University 1984;0(01):-
Objective To investigate the manifestation of HCC on superparamagnetic iron oxide(SPIO)-enhanced MRI in rats and clarify its pathologic basis in hope of the application of SPIO-enhanced MRI in estimation of histological grading in HCC.Methods HCC was induced chronically with 1 ml of 2% DEN solution once a day in 80 rats for 14 weeks,and another 10 rats served as normal controls.All rats received dynamic MR examinations on week 16,18,20,21,22,23,24,25.MR imaging was performed before and after SPIO injection using SE-T1WI,FMPSPGR-T1WI,GRE-T2WI,FSE-PDWI,FSE-T2WI, and the relative parameters were obtained.Rats were killed as soon as MRI finished.The tumors were observed grossly and the parts matched with the lesions on MRI were cut into pieces,stained with HE and PerIs,for pathologic examination.Results Kupffer cell number in HCCs was significantly smaller than that in normal liver tissues(P
4.Effects of interleukin-18 on transdifferentiation in renal tubular epithelial cells
Cuiwei YAO ; Dong LIANG ; Huafeng LIU ; Deshen TANG ; Xiaowen CHEN
Chinese Journal of Immunology 1986;0(04):-
Objective:To study the effect of interleukin-18 on transdifferentiation in renal tubular epithelial cells(TECs).Methods:Human proximal tubular epithelial cell line(HK-2) was cultured in vitro.TECs were exposed to different concentrations(0,0.1,1,10 and 100 ng/ml) of IL-18 for 24,48 and 72 hours.At the end of each incubation,the expressions of the ?-SMA and TGF-?_1 mRNA were assessed by RT-PCR,the rate of ?-SMA expressing TECs was assessed by immunocytochemistry,and the expression of the ?-SMA protein was assessed by Western blotting.Results:(1)The expressions of ?-SMA and TGF-?_1 mRNA were increased significantly by a dose- and time-dependent manner when TECs were exposed to IL-18(P
5.Clinical study of capecitabine or S-1 as maintenance treatment to patients with advanced gastric cancer
Liping ZHENG ; Nan ZHANG ; Ying PAN ; Cuiwei LIANG ; Wuxing GONG
The Journal of Practical Medicine 2017;33(16):2757-2760
Objective To evaluate the efficacy and adverse effect caused by capecitabine compared with S-1 as maintenance treatment of patients with advanced gastric cancer (AGC). Methods A total of 123 AGC patients who did not suffer disease progression after first-line chemotherapy were randomized into three groups. The capecitabine group(Cap)received maintenance chemotherapy with capecitabine(1000 mg/m2 twice daily for 14 days,21 days/cycle),and the S-1 group(S1)received S-1(40,50,or 60 mg according to the body surface area and orally administered twice a day for 14 days ,21 days/cycle). The observation group was given the support-ive treatment. Patients kept this chemotherapy regimens until disease progressed or with intolerant toxicity. Re-sults The disease control rate was 70.7%in the Cap group and 80.5%in the S1 group(P=0.304). The median time of progression was 8.3 months in the Cap group and 8.5 months in the S1 group(P = 0.448). Maintenance chemotherapy groups showed better responses in the treatment group than the observation group ,which demonstrat-ed a median progression of 6.7 months(P<0.001). The median overall survival time was 15.3 months in the Cap group and 15.7 months in the S1 group(P = 0.637). Maintenance chemotherapy groups showed better responses than the observation group ,which demonstrated a median survival of 12.8 months (P < 0.05). The main side effects included hyperpigmentation,bone marrow suppression,nausea and vomiting and hand-foot syndrome. No death occurred in relation to the therapy. Conclusion The effectiveness of capecitabine and S-1 as maintenance chemotherapy in AGC patients after the first-line chemotherapy are similar,and both can prolong the time of overall survival. And the adverse reactions can be tolerated.
6.An adaptive filtering algorithm applied to inhibit the interference from the ventricular during atrial epicardial mapping experiment.
Liqian SUN ; Liang LIU ; Yanlei WANG ; Cuiwei YANG
Chinese Journal of Medical Instrumentation 2011;35(4):243-245
This paper introduces an adaptive filtering algorithm based on the LMS principle to inhibit the ventricular interference in the atrial epicardial mapping experiments.
Algorithms
;
Electrocardiography
;
Epicardial Mapping
;
Heart Ventricles
7.The development for real-time sampling and display in epicardial mapping system.
Yanlei WANG ; Liqian SUN ; Liang LIU ; Cuiwei YANG ; Jianguo YU
Chinese Journal of Medical Instrumentation 2011;35(6):395-397
In order to realize real-time sampling and display in 128-channeled Epicardial Mapping System whose sampling frequency is 2 kHz per channel, the article introduces a mapping software and preliminarily validates its practicability. The software is designed in MFC, using multiple-thread technology and buffering and pumping values method.
Epicardial Mapping
;
Signal Processing, Computer-Assisted
;
Software
;
Software Design
8.Detection and clinical research of FMS-like tyrosine kinase-3, NPM1 and c-kit genes in bone marrow slides of patients with acute myeloid leukemia
Ying PAN ; Wuxing GONG ; Cuiwei LIANG ; Junxiang DU ; Dongxu PENG ; Yun XIE ; Liping ZHENG ; Nan ZHANG ; Sichao HUANG
Journal of Leukemia & Lymphoma 2016;25(3):163-168,173
Objective To study the FMS-like tyrosine kinase-3 (FLT3) gene, NPM1 gene and c-kit gene mutations in acute myeloid leukemia (AML) by extracting DNA from the storage of bone marrow slides, and to investigate the relationship between the three gene mutations and clinical features in AML. Methods The bone marrow slides of 55 patients diagnosed with AML were enrolled in this study. The PCR, DNA sequencing and molecular cloning were used to detect and analyse the FLT3-ITD, NPM1 and c-kit gene mutations. Patients' remission, progression and survival time were also recorded. Results The DNA was successfully extracted from the bone marrow slides with -20 ℃ frozen storage without Wright stained, chemically fixed, and room temperature storage Wright stained discoloured by phenol ∶ chloroform ∶ isoamyl alcohol method, which can be used in PCR, direct sequencing and molecular cloning sequencing analysis. 10 of the 55 cases (18.2 %) were FLT3-ITD positive, including 9 cases with heterozygous mutations and 1 case with homozygous mutation. FLT3-ITD positive group had lower complete remission (CR) rate, shorter event-free survival (EFS) time and overall survival (OS) time than the negative group (P< 0.05). 9 of the 55 cases (16.4 %) had NPM1 heterozygous gene mutations, all belonging to type A. The EFS rate of the patients with NPM1 mutation was higher in 10 months and the OS rate was higher in 19 months (P< 0.05). 3 of 9 NPM1 mutations patients were FLT3-ITD positive. The CR rates of the four groups after initial remission induction therapy in order were NPM1+FLT3-ITD-, NPM1-FLT3-ITD-, NPM1-FLT3-ITD+, NPM1+FLT3-ITD+(P<0.05). Besides, NPM1-FLT3-ITD+was a risk factor affecting the OS (RR=1.250, P=0.005). 2 of the 55 cases (3.6 %) had c-kit gene mutations, namely mutant D816H and mutant D816V. The c-kit gene mutations were not found in patients with FLT3-ITD and NPM1 mutations. Conclusions The FLT3-ITD mutation is a poor prognosis molecular marker in AML, and NPM1 mutation is a good factor for the prognosis. NPM1-FLT3-ITD+is a risk factor affecting OS. The rate of c-kit gene mutation is low in AML, without the overlap of FLT3 and NPM1 mutations.
9.Application value of serum LDH in advanced non-small cell lung cancer patients treated with EGFR-TKI
Liping ZHENG ; Yidan CHEN ; Nan ZHANG ; Wen QUAN ; Junxiang DU ; Cuiwei LIANG ; Wuxing GONG
Journal of International Oncology 2019;46(6):337-341
Objective To investigate the value of serum lactate dehydrogenase (LDH) in advanced non-small cell lung cancer (NSCLC) treated with epidermal growth factor receptor (EGFR)-tyrosine kinase inhibitor (TKI).Methods Pretreatment LDH level,pathological characteristic,tumor staging and treatment situation of 190 advanced NSCLC patients with EGFR sensitive mutation confirmed by pathology were retrospectively collected in Zhuhai People's Hospital of Guangdong Provice from July 2011 to July 2015.All the patients were divided into LDH normal group (LDH ≤252 U/L,n =78) and elevated group (LDH > 252 U/L,n =112) according to pretreatment LDH level.Inaging evaluations of the patients were performed regularly,and the progression-free survival (PFS) and overall survival (OS) were recorded.The survival curves were plotted by Kaplan-Meier method and survival difference between patients with different LDH level was compared by logrank test.Cox regression analysis was used to analyze prognostic factors for mortality.Results The objective response rate of the LDH normal group was 76.9% (60/78),and the elevated group was 71.4% (80/112),with no statistically significant difference (x2 =0.716,P =0.398).The disease control rate of the LDH normal group was 89.7% (70/78),and the elevated group was 85.7% (96/112),with no statistically significant difference (x2 =0.676,P =0.411).The median PFS of the LDH normal group was 11.5 months,and the elevated group was 9.7 months (x2 =5.92,P =0.015).The median OS was 31.0 months in the LDH normal group,and 26.1 months in the elevated LDH group (x2 =4.79,P =0.029).Both PFS and OS of patients with elevated LDH were shorter than those of patients with normal LDH.Cox multivariate regression analysis showed that tumor staging (HR =1.652,95% CI:1.386-2.259,P =0.018),PS score (HR =2.248,95% CI:1.507-3.846,P < 0.001),carcino-embryonic antigen (CEA) level (HR =1.250,95% CI:1.066-1.703,P =0.037) and LDH level (HR =1.771,95 % CI:1.324-1.947,P =0.015) were independent prognostic factors in patients with advanced NSCLC.Conclusion Pretreatment serum LDH can not affect the objective response rate and disease control rate of EGFR-TKI in the treatment of advanced NSCLC,but can affect the PFS and OS of patients.Pretreatment serum LDH is an independent prognostic factor.